Streetbeat News

Revenues

ASO

19 analysts have provided diverse opinions on Academy Sports (NASDAQ:ASO) over the past quarter, with a mix of bullish to bearish sentiments. The recent ratings show a shift towards a more bullish outlook, with an average 12-month price target of $79.11, up from $73.56. Analysts' actions range from maintaining to raising and lowering their price targets, reflecting their reaction to the company's performance and market conditions. Academy Sports has shown strong financial performance with a revenue growth rate of 2.77%, a net margin of 9.37%, and an ROE of 8.97%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 5:01 pm

EWBC

Eight analysts have recently updated their ratings and price targets for East West Bancorp (NASDAQ:EWBC), showing a mix of bullish and somewhat bullish opinions. The average 12-month price target has been raised to $88.88, up from $81.67, with a high estimate of $106.00 and a low of $76.00. Analyst actions include both upgrades and maintenance of ratings, reflecting a positive outlook on the company's performance despite a slight decline in revenue growth and a high debt-to-equity ratio. East West Bancorp's strong market presence, especially in the U.S. and China, along with its focus on commercial deposits and entertainment partnerships, supports its financial health as indicated by its net margin and ROE.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 5:01 pm

GLBE

Global E Online (NASDAQ:GLBE) received mixed analyst ratings, with an average 12-month price target of $45.67, reflecting an 8.74% increase from the previous target. The company's financial performance shows a positive revenue trend with a 38.77% growth rate, but challenges in profitability and efficiency metrics like net margin, ROE, and ROA. Its debt management is sound, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 5:00 pm

OPK

Recent analyst ratings for OPKO Health (NASDAQ:OPK) show a mix of bullish and somewhat bullish opinions, with an average 12-month price target of $2.75, indicating a 57.14% increase from the previous target. The company, a diversified biotech with operations in diagnostics and pharmaceuticals, faces challenges in revenue growth and asset utilization but has a strong net margin and ROE. Analysts maintain or adjust their ratings based on market conditions and company performance.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 5:00 pm

CSL

Analysts have updated their ratings and price targets for Carlisle Companies (NYSE:CSL), showing a positive outlook with an average 12-month price target of $399.75, marking a 10.66% increase from the previous target. The company's financial performance indicates a negative revenue trend but strong net margin and ROA, with challenges in ROE and a sound debt management position.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 5:00 pm

SKX

9 analysts have recently reviewed Skechers USA (NYSE:SKX), showing a mix of bullish and bearish sentiments. The average 12-month price target is $70.22, indicating a 4.54% increase from the previous target. Analyst actions include ratings adjustments and price target changes, reflecting market dynamics and company performance. Skechers USA's financial health is strong, with notable revenue growth, high net margin, and effective debt management. The company's market capitalization is below industry benchmarks, suggesting room for growth.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 4:00 pm

OZK

Five analysts have recently updated their ratings on Bank OZK (NASDAQ:OZK), showing a mix of opinions from bullish to bearish. The average 12-month price target is now $48.6, down from $51.67, indicating a negative sentiment shift. Analysts from Truist Securities, Citigroup, Wells Fargo, and Raymond James have adjusted their price targets and ratings, reflecting changes in market conditions and Bank OZK's performance. Bank OZK has shown strong financial performance with a revenue growth of 13.62%, a net margin of 41.18%, and above-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 4:00 pm

PLMR

Recent analyst ratings for Palomar Holdings (NASDAQ:PLMR) show a positive trend, with 5 analysts offering views ranging from bullish to indifferent. The average 12-month price target has been raised to $84.00, reflecting a 13.82% increase from the previous $73.80. Analysts from firms like Piper Sandler and Jefferies have raised their price targets, indicating a bullish outlook based on Palomar's strong financial performance, including a notable revenue growth rate of 18.92% and a high net margin of 24.57%.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 4:00 pm

ALGS

Aligos Therapeutics has received a $1.3 million contract from the National Institutes of Health (NIH) for the clinical development of a compound aimed at treating Covid-19.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 3:31 pm

RITM

In the last three months, 6 analysts have offered diverse ratings on Rithm Capital (NYSE:RITM), with recent actions including maintaining and raising price targets, reflecting a generally positive outlook. The average 12-month price target is $12.17, marking a 9.44% increase from the previous average of $11.12. Despite this optimism, Rithm Capital faces financial challenges, including a -21.17% decline in revenue growth and below-industry averages in net margin, ROE, and ROA, alongside a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 3:01 pm